Is Helius Medical Technologies Inc (NASDAQ: HSDT) Stock Poised for More Growth?

In the last trading session, 15.31 million Helius Medical Technologies Inc (NASDAQ:HSDT) shares changed hands as the company’s beta touched 1.17. With the company’s per share price at $1.09 changed hands at -$0.05 or -4.39% during last session, the market valuation stood at $0.58M. HSDT’s last price was a discount, traded about -2101.83% off its 52-week high of $24.00. The share price had its 52-week low at $0.80, which suggests the last value was 26.61% up since then.

Analysts gave the Helius Medical Technologies Inc (HSDT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended HSDT as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight.

Helius Medical Technologies Inc (NASDAQ:HSDT) trade information

Instantly HSDT was in red as seen at the end of in last trading. With action -73.38%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -89.16%, with the 5-day performance at -73.38% in the red. However, in the 30-day time frame, Helius Medical Technologies Inc (NASDAQ:HSDT) is -73.86% down.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 63.29%. The 2025 estimates are for Helius Medical Technologies Inc earnings to increase by 85.22%.

HSDT Dividends

Helius Medical Technologies Inc is expected to release its next quarterly earnings report in July.

Among Mutual Funds, the top two as of Mar 31, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . With 1.92 shares estimated at $2091.0 under it, the former controlled 0.02% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held about 0.01% of the shares, roughly 414.0 shares worth around $451.0.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.